Literature DB >> 22114207

Macrophages mediate lung inflammation in a mouse model of ischemic acute kidney injury.

Christopher Altmann1, Ana Andres-Hernando, Rachel H McMahan, Nilesh Ahuja, Zhibin He, Chris J Rivard, Charles Louis Edelstein, Lea Barthel, William J Janssen, Sarah Faubel.   

Abstract

Serum IL-6 is increased in acute kidney injury (AKI) and inhibition of IL-6 reduces AKI-mediated lung inflammation. We hypothesized that circulating monocytes produce IL-6 and that alveolar macrophages mediate lung inflammation after AKI via chemokine (CXCL1) production. To investigate systemic and alveolar macrophages in lung injury after AKI, sham operation or 22 min of renal pedicle clamping (AKI) was performed in three experimental settings: 1) systemic macrophage depletion via diphtheria toxin (DT) injection to CD11b-DTR transgenic mice, 2) DT injection to wild-type mice, and 3) alveolar macrophage depletion via intratracheal (IT) liposome-encapsulated clodronate (LEC) administration to wild-type mice. In mice with AKI and systemic macrophage depletion (CD11b-DTR transgenic administered DT) vs. vehicle-treated AKI, blood monocytes and lung interstitial macrophages were reduced, renal function was similar, serum IL-6 was increased, lung inflammation was improved, lung CXCL1 was reduced, and lung capillary leak was increased. In wild-type mice with AKI administered DT vs. vehicle, serum IL-6 was increased. In mice with AKI and alveolar macrophage depletion (IT-LEC) vs. AKI with normal alveolar macrophage content, blood monocytes and lung interstitial macrophages were similar, alveolar macrophages were reduced, renal function was similar, lung inflammation was improved, lung CXCL1 was reduced, and lung capillary leak was increased. In conclusion, administration of DT in AKI is proinflammatory, limiting the use of the DTR-transgenic model to study systemic effects of AKI. Mice with AKI and either systemic mononuclear phagocyte depletion or alveolar macrophage depletion had reduced lung inflammation and lung CXCL1, but increased lung capillary leak; thus, mononuclear phagocytes mediate lung inflammation, but they protect against lung capillary leak after ischemic AKI. Since macrophage activation and chemokine production are key events in the development of acute lung injury (ALI), these data provide further evidence that AKI may cause ALI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22114207      PMCID: PMC3289418          DOI: 10.1152/ajprenal.00559.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  47 in total

1.  Mortality and costs of acute renal failure associated with amphotericin B therapy.

Authors:  D W Bates; L Su; D T Yu; G M Chertow; D L Seger; D R Gomes; E J Dasbach; R Platt
Journal:  Clin Infect Dis       Date:  2001-02-21       Impact factor: 9.079

Review 2.  The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS.

Authors:  G J Bellingan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

3.  Refining predictive models in critically ill patients with acute renal failure.

Authors:  Ravindra L Mehta; Maria T Pascual; Carmencita G Gruta; Shunping Zhuang; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

Review 4.  Role of the neutrophil in septic shock and the adult respiratory distress syndrome.

Authors:  Andrew J Aldridge
Journal:  Eur J Surg       Date:  2002

5.  Inhibition of VEGF receptors causes lung cell apoptosis and emphysema.

Authors:  Y Kasahara; R M Tuder; L Taraseviciene-Stewart; T D Le Cras; S Abman; P K Hirth; J Waltenberger; N F Voelkel
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

6.  Protective role of macrophages in noninflammatory lung injury caused by selective ablation of alveolar epithelial type II Cells.

Authors:  Yasunobu Miyake; Hitomi Kaise; Kyo-Ichi Isono; Haruhiko Koseki; Kenji Kohno; Masato Tanaka
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

7.  Interleukin-10 inhibits pulmonary NF-kappaB activation and lung injury induced by hepatic ischemia-reperfusion.

Authors:  H Yoshidome; A Kato; M J Edwards; A B Lentsch
Journal:  Am J Physiol       Date:  1999-11

8.  Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome.

Authors:  Elisa Estenssoro; Arnaldo Dubin; Enrique Laffaire; Héctor Canales; Gabriela Sáenz; Miriam Moseinco; Mario Pozo; Alejandro Gómez; Natalio Baredes; Gustavo Jannello; Javier Osatnik
Journal:  Crit Care Med       Date:  2002-11       Impact factor: 7.598

9.  Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients.

Authors:  Philipp G H Metnitz; Claus G Krenn; Heinz Steltzer; Thomas Lang; Jürgen Ploder; Kurt Lenz; Jean-Roger Le Gall; Wilfred Druml
Journal:  Crit Care Med       Date:  2002-09       Impact factor: 7.598

10.  Renal dysfunction in allogeneic hematopoietic cell transplantation.

Authors:  Chirag R Parikh; Peter A McSweeney; Didem Korular; Tevfik Ecder; Aicha Merouani; Jeremy Taylor; Vicki Slat-Vasquez; Elizabeth J Shpall; Roy B Jones; Scott I Bearman; Robert W Schrier
Journal:  Kidney Int       Date:  2002-08       Impact factor: 10.612

View more
  23 in total

1.  Cytokine production increases and cytokine clearance decreases in mice with bilateral nephrectomy.

Authors:  Ana Andres-Hernando; Belda Dursun; Christopher Altmann; Nilesh Ahuja; Zhibin He; Rhea Bhargava; Charles E Edelstein; Alkesh Jani; Thomas S Hoke; Christina Klein; Sarah Faubel
Journal:  Nephrol Dial Transplant       Date:  2012-07-09       Impact factor: 5.992

2.  Artesunate Inhibits Renal Ischemia-Reperfusion-Mediated Remote Lung Inflammation Through Attenuating ROS-Induced Activation of NLRP3 Inflammasome.

Authors:  Zhaohui Liu; Min Qu; Lili Yu; Panpan Song; Yulin Chang
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

Review 3.  Mechanisms and mediators of lung injury after acute kidney injury.

Authors:  Sarah Faubel; Charles L Edelstein
Journal:  Nat Rev Nephrol       Date:  2015-10-06       Impact factor: 28.314

4.  Acute Kidney Injury as a Risk Factor for Delirium and Coma during Critical Illness.

Authors:  Edward D Siew; William H Fissell; Christina M Tripp; Jeffrey D Blume; Matthew D Wilson; Amanda J Clark; Andrew J Vincz; E Wesley Ely; Pratik P Pandharipande; Timothy D Girard
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

Review 5.  Mouse model of ischemic acute kidney injury: technical notes and tricks.

Authors:  Qingqing Wei; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2012-09-19

6.  Bacillary replication and macrophage necrosis are determinants of neutrophil recruitment in tuberculosis.

Authors:  Teresa Repasy; Nuria Martinez; Jinhee Lee; Kim West; Wenjun Li; Hardy Kornfeld
Journal:  Microbes Infect       Date:  2015-04-07       Impact factor: 2.700

7.  Imaging mRNA expression levels in living cells with PNA·DNA binary FRET probes delivered by cationic shell-crosslinked nanoparticles.

Authors:  Zhenghui Wang; Ke Zhang; Yuefei Shen; Jillian Smith; Sharon Bloch; Samuel Achilefu; Karen L Wooley; John-Stephen Taylor
Journal:  Org Biomol Chem       Date:  2013-03-28       Impact factor: 3.876

8.  Efficient protection and transfection of small interfering RNA by cationic shell-crosslinked knedel-like nanoparticles.

Authors:  Yuefei Shen; Huafeng Fang; Ke Zhang; Ritu Shrestha; Karen L Wooley; John-Stephen A Taylor
Journal:  Nucleic Acid Ther       Date:  2013-04       Impact factor: 5.486

9.  Suppression of inflammatory cell trafficking and alveolar simplification by the heme oxygenase-1 product carbon monoxide.

Authors:  Anuli C Anyanwu; J Kelley Bentley; Antonia P Popova; Omar Malas; Husam Alghanem; Adam M Goldsmith; Marc B Hershenson; David J Pinsky
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-14       Impact factor: 5.464

Review 10.  Distant Organ Dysfunction in Acute Kidney Injury: A Review.

Authors:  Sul A Lee; Martina Cozzi; Errol L Bush; Hamid Rabb
Journal:  Am J Kidney Dis       Date:  2018-06-14       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.